Search Results 521-530 of 38770 for Two-phase

  1. Farsightedness - Symptoms and causes - Mayo Clinic

    Nearby objects appear blurry. You need to squint to see clearly. · First exam at 40. Every 2 to 4 years between ages 40 and 54. · Starting in the newborn phase ...

  2. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

    Background: Sometimes the cancer advanced alveolar soft part sarcoma (ASPS) cannot be helped with surgery or other treatment. The drug atezolizumab unblocks the ...

  3. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  4. Impact of CardiolRxTM on Recurrent Pericarditis - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. A Phase 1b/2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma - Mayo Clinic

    About this study. This is a Phase 1b/2, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of B-701 plus docetaxel versus ...

  6. Oncology (Medical) - Clinical trials

    The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as ...

  7. PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Shoulder replacement surgery - Mayo Clinic

    The surgery usually takes 1 to 2 hours. After the procedure. After surgery ... Surgical management of end-stage rheumatoid arthritis. https://www ...

  9. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 90% of the patients with Waldenström's macroglobulinemia.

  10. A Global Study To Assess The Drug Dynamics, Efficacy, And Safety Of GZ/SAR402671 In Parkinson's Disease Patients Carrying A Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

    - Part 2: To determine the efficacy of GZ/SAR402671 administered orally daily, as compared to placebo in patients with early-stage Parkinson's disease carrying ...